Cisplatin: all 1,652 studies that test it
Page 13 of 17. Open to participants first (223), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric CancerCompletedNCT00675194Phase 2
- The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaStatus unknownNCT00674167Phase 2
- Chemotherapy and Radiation Following Pancreatic SurgeryCompletedNCT00660270Phase 2
- S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by SurgeryStatus unknownNCT00659113Phase 2
- Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder CancerTerminatedNCT00635726Phase 2
- Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal CancerStatus unknownNCT00632333Phase 1
- Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric CancerCompletedNCT00632268Phase 2
- Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck CancerCompletedNCT00629226Phase 1
- Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)WithdrawnNCT00627835Phase 1
- Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerStatus unknownNCT00625937Phase 2
- Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerCompletedNCT00623064Phase 1
- Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung CancerCompletedNCT00622349Phase 3
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00616785Phase 2
- Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsCompletedNCT00602082Phase 2
- Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00601692Phase 1
- Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach CancerCompletedNCT00601510Phase 1
- Gemcitabine and Cisplatin as First Line Combination Therapy in Patients With Triple-negative MBCCompletedNCT00601159Phase 2
- Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung CancerCompletedNCT00582634Phase 2
- Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
- Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid TumorsCompletedNCT00573690Phase 1
- Study of Weekly DCF to Treat Advanced Gastric CancerTerminatedNCT00568971Phase 2
- Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder CancerCompletedNCT00556621Phase 1/2
- Phase I Study of CBP501 and Cisplatin in Patients With Advanced Refractory Solid TumorsCompletedNCT00551512Phase 1
- Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell TumorsStatus unknownNCT00551122Phase 1/2
- Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00550901Phase 1
- Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00550784Phase 1
- Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical CancerStatus unknownNCT00548821Phase 3
- Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung CancerStatus unknownNCT00546130Phase 2
- R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung CancerCompletedNCT00544596Phase 1
- Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00544362Phase 1/2
- Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by SurgeryCompletedNCT00541073Phase 2
- Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast CancerCompletedNCT00538525Not applicable
- Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell CancerTerminatedNCT00531687Phase 2
- A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00528619Phase 1
- Taxotere/Temodar/Cisplatin Study in Melanoma PatientsCompletedNCT00527761Phase 1
- CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC PatientsTerminatedNCT00526643Phase 3
- STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing StudyStatus unknownNCT00526396Phase 3
- Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and CisplatinTerminatedNCT00516750Phase 2
- A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical CancerCompletedNCT00510250Phase 1/2
- Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver InvolvementCompletedNCT00507962Phase 1
- Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/ChemotherapyTerminatedNCT00505492Phase 2
- Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical TrialCompletedNCT00502463Not applicable
- Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersCompletedNCT00498979Phase 1
- Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCompletedNCT00496275Phase 1
- Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III MelanomaStatus unknownNCT00492505Phase 2
- Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00491127Phase 2
- Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder CancerCompletedNCT00490880Phase 2
- Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive NodesCompletedNCT00490659Phase 2
- Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract CarcinomasCompletedNCT00490399Phase 2
- Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung CancerCompletedNCT00489996Phase 2
- Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaStatus unknownNCT00489944Phase 2
- Study of NGR-hTNF in Combination With Cisplatin in Solid TumorCompletedNCT00483093Phase 1
- Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast CancerCompletedNCT00480597Phase 2
- A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric CancerCompletedNCT00477711Phase 2
- Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic PatientsTerminatedNCT00470340Phase 3
- Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerStatus unknownNCT00462397Phase 2
- Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant MesotheliomaCompletedNCT00458913Phase 2
- Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary TumorWithdrawnNCT00458315Phase 2
- Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)CompletedNCT00452634Phase 2
- Open Label, Phase I ZD6474 Head and Neck Cancer StudyCompletedNCT00450138Phase 1
- Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by SurgeryCompletedNCT00448643Phase 1
- Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryCompletedNCT00445861Phase 1/2
- Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and NeckCompletedNCT00442455Phase 3
- Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00432315Phase 2
- Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical CancerWithdrawnNCT00428194Phase 1
- Cisplatin and Everolimus in Treating Patients With Advanced Solid TumorsCompletedNCT00423865Phase 1
- Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415324Phase 1
- Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial CancerActive, not recruitingNCT00411138Phase 3
- Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)Active, not recruitingNCT00407186Phase 3
- Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck CancerCompletedNCT00405405Phase 1
- Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant MesotheliomaCompletedNCT00402766Phase 1
- C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00402545Phase 1
- MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung CancerCompletedNCT00401492Phase 2
- Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT00401323Phase 2/3
- Evaluating Patients With Impaired Hepatic FunctionCompletedNCT00398424Phase 1
- Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerStatus unknownNCT00398385Phase 2
- Evaluating Patients With Varying Degrees of Renal FunctionCompletedNCT00398307Phase 1
- Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by SurgeryTerminatedNCT00389688Phase 2
- Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung CancerCompletedNCT00388960Phase 2
- Preoperative Treatment of Patients With High Risk ThymomaCompletedNCT00387868Phase 2
- Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00387699Phase 2
- Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural MesotheliomaCompletedNCT00386815Phase 2
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric CancerStatus unknownNCT00384878Phase 2
- Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to BrachytherapyCompletedNCT00379665Phase 2
- Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaTerminatedNCT00367497Phase 2
- Cisplatin and Temozolomide in Treating Young Patients With Malignant GliomaStatus unknownNCT00360945Phase 2
- A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung CancerCompletedNCT00359359Phase 1/2
- Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaCompletedNCT00354393Phase 2
- Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractCompletedNCT00353015Phase 2
- A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung CancerCompletedNCT00349492Phase 3
- TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerCompletedNCT00349219Phase 3
- Chemoradiotherapy Followed by Surgery for Advanced Paranasal Sinus CancerWithdrawnNCT00347256Not applicable
- CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00346801Phase 1
- Docetaxel in Locally Advanced Gastric AdenocarcinomaCompletedNCT00343239Phase 2
- A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck CancerCompletedNCT00337532Phase 2/3
- Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic MalignanciesCompletedNCT00335998Phase 1
- Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00335543Phase 2
- Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.CompletedNCT00330499Phase 3
- Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung CancerWithdrawnNCT00329472Phase 3